Oct 31, 2020
Aravax appoints Financial Executive Thomas Ulmer to Board of Directors
01 November, 2020, Melbourne, Victoria - Aravax, a clinical stage biotechnology company focused on developing the first safe and rapidly...
top of page
Developing safe, convenient, disease-modifying treatments for food allergies.
.jpg)
News
bottom of page